Buscar
01/11/2021
Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias
Alcolea, D, Delaby, C, Munoz, L, Torres, S, Estelles, T, Zhu, N, Barroeta, I, Carmona-Iragui, M, Illan-Gala, I, Santos-Santos, MA, Altuna, M, Sala, I, Sanchez-Saudinos, MB, Videla, L, Valldeneu, S, Subirana, A, Pegueroles, J, Hirtz, C, Vialaret, J, Lehmann, S, Karikari, TK, Ashton, NJ, Blennow, K, Zetterberg, H, Belbin, O, Blesa, R, Clarimon, J, Fortea, J, Lleo, A. Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2021; 92(11)DOI:10.1136/jnnp-2021-326603. PMID:34103344. IF:13.654(Q1/1D).
01/11/2021
Cytokines as new biomarkers of skin wound vitality
Peyron, PA, Colomb, S, Becas, D, Adriansen, A, Gauchotte, G, Tiers, L, Marin, G, Lehmann, S, Baccino, E, Delaby, C, Hirtz, C. Cytokines as new biomarkers of skin wound vitality. INTERNATIONAL JOURNAL OF LEGAL MEDICINE. 2021; 135(6)DOI:10.1007/s00414-021-02659-z. PMID:34313846. IF:2.791(Q1/3D).
01/11/2021
Alzheimer's disease associated with Down syndrome: a genetic form of dementia
Fortea, J, Zaman, SH, Hartley, S, Rafii, MS, Head, E, Carmona-Iragui, M. Alzheimer's disease associated with Down syndrome: a genetic form of dementia. LANCET NEUROLOGY. 2021; 20(11)DOI:10.1016/S1474-4422(21)00245-3. PMID:34687637. IF:59.935(Q1/1D).
01/11/2021
Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort
Xu, J, Green, R, Kim, M, Lord, J, Ebshiana, A, Westwood, S, Baird, AL, Nevado-Holgado, AJ, Shi, L, Hye, A, Snowden, SG, Bos, I, Vos, SJB, Vandenberghe, R, Teunissen, CE, Kate, MT, Scheltens, P, Gabel, S, Meersmans, K, Blin, O, Richardson, J, De Roeck, EE, Engelborghs, S, Sleegers, K, Bordet, R, Rami, L, Kettunen, P, Tsolaki, M, Verhey, FRJ, Alcolea, D, Lleo, A, Peyratout, G, Tainta, M, Johannsen, P, Freund-Levi, Y, Froelich, L, Dobricic, V, Frisoni, GB, Molinuevo, JL, Wallin, A, Popp, J, Martinez-Lage, P, Bertram, L, Blennow, K, Zetterberg, H, Streffer, J, Visser, PJ, Lovestone, S, Proitsi, P, Legido-Quigley, C. Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort. Biomedicines. 2021; 9(11)DOI:10.3390/biomedicines9111610. PMID:34829839. IF:4.757(Q2/4D).
18/10/2021
Homozygous R136S mutation in PRNP gene causes inherited early onset prion disease
Ximelis, T, Marin-Moreno, A, Espinosa, JC, Erana, H, Charco, JM, Hernandez, I, Riveira, C, Alcolea, D, Gonzalez-Roca, E, Aldecoa, I, Molina-Porcel, L, Parchi, P, Rossi, M, Castilla, J, Ruiz-Garcia, R, Gelpi, E, Torres, JM, Sanchez-Valle, R. Homozygous R136S mutation in PRNP gene causes inherited early onset prion disease. Alzheimers Research & Therapy. 2021; 13(1)DOI:10.1186/s13195-021-00912-6. PMID:34663460. IF:8.831(Q1/1D).
04/10/2021
Divergent connectomic organization delineates genetic evolutionary traits in the human brain
Bueicheku, E, Gonzalez-de-Echavarri, JM, Ortiz-Teran, L, Montal, V, Uquillas, FD, De Marcos, L, Orwig, W, Kim, CM, Ortiz-Teran, E, Basaia, S, Diez, I, Sepulcre, J. Divergent connectomic organization delineates genetic evolutionary traits in the human brain. Scientific Reports. 2021; 11(1)DOI:10.1038/s41598-021-99082-6. PMID:34608211. IF:4.997(Q2/3D).
26/09/2021
Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer's disease
Barranco, N, Pla, V, Alcolea, D, Sanchez-Dominguez, I, Fischer-Colbrie, R, Ferrer, I, Lleo, A, Aguado, F. Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer's disease. Translational Neurodegeneration. 2021; 10(1)DOI:10.1186/s40035-021-00263-0. PMID:34565482. IF:9.883(Q1/1D).
24/09/2021
Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathy
De Kort, AM, Kuiperij, HB, Alcolea, D, Kersten, I, Versleijen, AAM, Greenberg, SM, Stoops, E, Schreuder, FHBM, Klijn, CJM, Lleo, A, Claassen, JAHR, Verbeek, MM. Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathy. Alzheimers Research & Therapy. 2021; 13(1)DOI:10.1186/s13195-021-00899-0. PMID:34560885. IF:8.831(Q1/1D).
01/09/2021
CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals
Tijms, BM, Gobom, J, Teunissen, C, Dobricic, V, Tsolaki, M, Verhey, F, Popp, J, Martinez-Lage, P, Vandenberghe, R, Lleo, A, Molinuevo, JL, Engelborghs, S, Freund-Levi, Y, Froelich, L, Bertram, L, Lovestone, S, Streffer, J, Vos, S, Blennow, K, Scheltens, P, Zetterberg, H, Visser, PJ, ADNI. CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals. Proteomes. 2021; 9(3)DOI:10.3390/proteomes9030036. PMID:34449748. IF:(Q/D).
01/09/2021
Small Neuron-Derived Extracellular Vesicles from Individuals with Down Syndrome Propagate Tau Pathology in the Wildtype Mouse Brain
Ledreux, A, Thomas, S, Hamlett, ED, Trautman, C, Gilmore, A, Hager, ER, Paredes, DA, Margittai, M, Fortea, J, Granholm, AC. Small Neuron-Derived Extracellular Vesicles from Individuals with Down Syndrome Propagate Tau Pathology in the Wildtype Mouse Brain. Journal of Clinical Medicine. 2021; 10(17)DOI:10.3390/jcm10173931. PMID:34501378. IF:4.964(Q2/4D).
01/09/2021
Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes
Horta-Barba, A, Pagonabarraga, J, Martinez-Horta, S, Busteed, L, Pascual-Sedano, B, Illan-Gala, I, Marin-Lahoz, J, Aracil-Bolanos, I, Perez-Perez, J, Sampedro, F, Bejr-Kasem, H, Kulisevsky, J. Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes. JOURNAL OF NEUROLOGY. 2021; 268(9)DOI:10.1007/s00415-021-10511-y. PMID:33704556. IF:6.682(Q1/2D).
01/09/2021
Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome
Montal, V, Barroeta, I, Bejanin, A, Pegueroles, J, Carmona-Iragui, M, Altuna, M, Benejam, B, Videla, L, Fernandez, S, Padilla, C, Aranha, MR, Iulita, MF, Vidal-Pineiro, D, Alcolea, D, Blesa, R, Lleo, A, Fortea, J. Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome. ANNALS OF NEUROLOGY. 2021; 90(3)DOI:10.1002/ana.26178. PMID:34309066. IF:11.274(Q1/1D).
19/08/2021
Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients
Solana, E, Martinez-Heras, E, Montal, V, Vilaplana, E, Lopez-Soley, E, Radua, J, Sola-Valls, N, Montejo, C, Blanco, Y, Pulido-Valdeolivas, I, Sepulveda, M, Andorra, M, Berenguer, J, Villoslada, P, Martinez-Lapiscina, EH, Prados, F, Saiz, A, Fortea, J, Llufriu, S. Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients. Scientific Reports. 2021; 11(1)DOI:10.1038/s41598-021-96132-x. PMID:34413373. IF:4.997(Q2/3D).
01/08/2021
Comparison of COVID-19 and Non-COVID-19 Pneumonia in Down Syndrome
de Asua, DR, Mayer, MA, Ortega, MD, Borrel, JM, Bermejo, TD, Gonzalez-Lamuno, D, Manso, C, Moldenhauer, F, Carmona-Iragui, M, Huls, A, Sherman, SL, Strydom, A, de la Torre, R, Dierssen, M, Spanish Trisomy 21 Res Soc COVID-1. Comparison of COVID-19 and Non-COVID-19 Pneumonia in Down Syndrome. Journal of Clinical Medicine. 2021; 10(16)DOI:10.3390/jcm10163748. PMID:34442043. IF:4.964(Q2/4D).
01/08/2021
Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study
Carmona-Iragui, M, Alcolea, D, Barroeta, I, Videla, L, Munoz, L, Van Pelt, KL, Schmitt, FA, Lightner, DD, Koehl, LM, Jicha, G, Sacco, S, Mircher, C, Pape, SE, Hithersay, R, Clare, ICH, Holland, AJ, Nubling, G, Levin, J, Zaman, SH, Strydom, A, Rebillat, AS, Head, E, Blesa, R, Lleo, A, Fortea, J. Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study. LANCET NEUROLOGY. 2021; 20(8)DOI:10.1016/S1474-4422(21)00129-0. PMID:34302785. IF:59.935(Q1/1D).
21/07/2021
Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies
Shi, L, Buckley, NJJ, Bos, I, Engelborghs, S, Sleegers, K, Frisoni, GB, Wallin, A, Lleo, A, Popp, J, Martinez-Lage, P, Legido-Quigley, C, Barkhof, F, Zetterberg, H, Visser, PJ, Bertram, L, Lovestone, S, Nevado-Holgado, AJ. Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies. Frontiers in Aging Neuroscience. 2021; 13DOI:10.3389/fnagi.2021.712545. PMID:34366831. IF:5.702(Q1/3D).
04/07/2021
Cognitive and brain cytokine profile of non-demented individuals with cerebral amyloid-beta deposition
Flores-Aguilar, L, Iulita, MF, Orciani, C, Tanna, N, Yang, JY, Bennett, DA, Cuello, AC. Cognitive and brain cytokine profile of non-demented individuals with cerebral amyloid-beta deposition. Journal of Neuroinflammation. 2021; 18(1)DOI:10.1186/s12974-021-02169-0. PMID:34218796. IF:9.589(Q1/1D).
01/07/2021
Epilepsy in Down Syndrome: A Highly Prevalent Comorbidity
Altuna, M, Gimenez, S, Fortea, J. Epilepsy in Down Syndrome: A Highly Prevalent Comorbidity. Journal of Clinical Medicine. 2021; 10(13)DOI:10.3390/jcm10132776. PMID:34202784. IF:4.964(Q2/4D).
01/07/2021
Sleep Disorders in Adults with Down Syndrome
Gimenez, S, Altuna, M, Blessing, E, Osorio, RM, Fortea, J. Sleep Disorders in Adults with Down Syndrome. Journal of Clinical Medicine. 2021; 10(14)DOI:10.3390/jcm10143012. PMID:34300177. IF:4.964(Q2/4D).
01/07/2021
Accelerated long-term forgetting in individuals with subjective cognitive decline and amyloid-beta positivity
Tort-Merino, A, Valech, N, Laine, M, Olives, J, Leon, M, Ecay-Torres, M, Estanga, A, Martinez-Lage, P, Fortea, J, Molinuevo, JL, Sanchez-Valle, R, Rodriguez-Fornells, A, Rami, L. Accelerated long-term forgetting in individuals with subjective cognitive decline and amyloid-beta positivity. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2021; 36(7)DOI:10.1002/gps.5539. PMID:33792089. IF:3.850(Q2/3D).